Posted in Regulatory MSD secures EC approval for Enflonsia to prevent infant RSV infection April 20, 2026 Pharmaceutical Business Review This approval authorises Enflonsia’s marketing across all 27 European Union member states, Iceland, Liechtenstein and Norway. RegulatoryInfectious DiseaseRead full story